Indo US Bio-Tech Ltd Q3 FY2025-2026 Results: Summary

Revenue
₹22.80Cr
Net Profits
₹3.00Cr
Net Profit Margins
13.16%
Highlights
Revenue:

Indo US Bio-Tech Ltd’s revenue fell -3.31% since last year same period to ₹22.80Cr in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -26.14% fall in its revenue since last 3-months.

Net Profits:

Indo US Bio-Tech Ltd’s net profit fell -40.59% since last year same period to ₹3.00Cr in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -13.04% fall in its net profits since last 3-months.

Net Profit Margins:

Indo US Bio-Tech Ltd’s net profit margin fell -38.56% since last year same period to 13.16% in the Q3 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated 17.73% jumped in its net profit margins since last 3-months.

FAQs

What was the revenue for Indo US Bio-Tech Ltd in Q3 results 2025?

The revenue for Indo US Bio-Tech Ltd in the Q3 results 2025 was ₹22.80Cr.

What was the net profit for Indo US Bio-Tech Ltd in Q3 results 2025?

The net profit for Indo US Bio-Tech Ltd in the Q3 results 2025 was ₹3.00Cr.

What was the net profit margin for Indo US Bio-Tech Ltd in Q3 results 2025?

The net profit margin for Indo US Bio-Tech Ltd in the Q3 results 2025 was 13.16%.

What was the revenue for Indo US Bio-Tech Ltd in Q3 results 2024?

The revenue for Indo US Bio-Tech Ltd in the Q3 results 2024 was ₹23.58Cr.

What was the net profit for Indo US Bio-Tech Ltd in Q3 results 2024?

The net profit for Indo US Bio-Tech Ltd in the Q3 results 2024 was ₹5.05Cr.

What was the net profit margin for Indo US Bio-Tech Ltd in Q3 results 2024?

The net profit margin for Indo US Bio-Tech Ltd in the Q3 results 2024 was 21.42%.